LGALS3 and type 2 diabetes mellitus: Gal-3 is more likely to be clinically useful as part of a multi-analyte panel that reflects overlapping metabolic, inflammatory, and fibrotic pathways involved in colorectal carcinogenesis among patients with T2D.